Indian Journal of Pharmaceutical Sciences
Users online: 23
Scientific Publication of the Indian Pharmaceutical Association
Home Email this page Print this page Bookmark this page Decrease font size Default font size Increase font size
The Journal Search Current Issue Archives Instructions Online submission Login  
REVIEW ARTICLE
Year : 2009  |  Volume : 71  |  Issue : 1  |  Page : 1-7

Drug use in pregnancy; a point to ponder!


1 Department of Pharmacology, A. R. College of Pharmacy, Vallabh Vidyanagar-388 120, India
2 Department of Pharmacology, Sat Kaival College of Pharmacy, Sarsa-388 365, India

Correspondence Address:
Punam Sachdeva
Department of Pharmacology, A. R. College of Pharmacy, Vallabh Vidyanagar-388 120
India
Login to access the Email id


DOI: 10.4103/0250-474X.51941

PMID: 20177448

Get Permissions

Pregnancy is a special physiological condition where drug treatment presents a special concern because the physiology of pregnancy affects the pharmacokinetics of medications used and certain medications can reach the fetus and cause harm. Total avoidance of pharmacological treatment in pregnancy is not possible and may be dangerous because some women enter pregnancy with medical conditions that require ongoing and episodic treatment (e.g. asthma, epilepsy, hypertension). Also during pregnancy new medical problems can develop and old ones can be exacerbated (e.g. migraine, headache) requiring pharmacological therapy. The fact that certain drugs given during pregnancy may prove harmful to the unborn child is one of the classical problems in medical treatment. In 1960's pregnant ladies who ingested thalidomide gave birth to children with phocomalia. Various other examples of teratogenic effects of drugs are known. It has been documented that congenital abnormalities caused by human teratogenic drugs account for less than 1% of total congenital abnormalities. Hence in 1979, Food and Drug Administration developed a system that determines the teratogenic risk of drugs by considering the quality of data from animal and human studies. FDA classifies various drugs used in pregnancy into five categories, categories A, B, C, D and X. Category A is considered the safest category and category X is absolutely contraindicated in pregnancy. This provides therapeutic guidance for the clinician. This article focuses on various aspects relating to drug use during pregnancy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed6431    
    Printed195    
    Emailed11    
    PDF Downloaded997    
    Comments [Add]    
    Cited by others 7    

Recommend this journal